2025-07-05 - Analysis Report
Okay, here's an analysis of Schrodinger Inc. (SDGR) based on the provided data, structured as requested.

## Schrodinger Inc. (SDGR) Analysis

**Company Overview:** Schrodinger Inc. is a company that develops software for drug discovery and materials science.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return:** SDGR: -51.15%, VOO: 52.26%
*   **Divergence:** -102.6 (SDGR significantly underperforming VOO)
*   **Relative Divergence:** 0.0 (Indicates the divergence is at the lowest end of its historical range)

**Analysis:** SDGR has significantly underperformed the S&P 500. The relative divergence suggests this underperformance is near its worst historical level.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha   | Beta   | Cap(B) |
|------------|--------|-------|---------|--------|--------|
| 2020-2022  | -74.0% | 68.9% | -89.0%  | -0.1   | 1.4    |
| 2021-2023  | -65.0% | 68.9% | -83.0%  | -0.0   | 2.6    |
| 2022-2024  | 8.0%  | 72.4% | -17.0%  | -0.0   | 1.4    |
| 2023-2025  | 2.0%  | 74.0% | -46.0%  | -0.0   | 1.6    |

**Analysis:**

*   **CAGR:** Shows negative compound annual growth rates across different periods, except for recent periods (2022-2024 and 2023-2025) where it shows slight positive growth.
*   **MDD:** High Maximum Drawdown (MDD) indicates significant volatility and potential risk.
*   **Alpha:**  Significantly negative Alpha suggests considerable underperformance relative to the market.
*   **Beta:** Beta values close to 0 indicate very low correlation with the S&P 500.

**2. Recent Stock Price Movement**

*   **Current Price:** \$21.12
*   **Last Market Change:** Price: \$21.12, Previous Close: \$20.96, Change: 0.76
*   **5-day Moving Average:** \$20.718
*   **20-day Moving Average:** \$22.0098
*   **60-day Moving Average:** \$23.075

**Analysis:** The stock price has experienced a slight increase in the most recent period. However, the current price is below both the 20-day and 60-day moving averages, suggesting a possible short-term downtrend despite the recent uptick.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.3301 (Low Risk)
*   **RSI:** 32.19 (Approaching oversold territory)
*   **PPO:** -0.0886
*   **Hybrid Signal:** cash_70%_Sell 69.9% of holdings (1051 shares - Caution - MRI:0.35) (Cash Ratio: 70% on 2025-06-16)
*   **Recent (20-day) Relative Divergence Change:** 0.0 (Short-term decrease)
*   **Expected Return (%):** -5608.3% (Very negative expected return, indicating significant risk compared to the S&P 500 over a long-term investment)

**Analysis:** The MRI indicates low market risk, but the RSI suggests the stock might be oversold. The negative PPO reinforces the downtrend. The "Hybrid Signal" suggests a cautious approach with a recommendation to reduce holdings and increase cash. The significantly negative expected return is a major red flag. Given the price change, this could be a minor rebound after a period of decline, but the overall indicators are concerning.

**4. Recent News & Significant Events**

*   **2025-07-01:** Schrodinger Inc (SDGR) has recently made headlines due to major business developments, regulatory changes, or market events.
*   **2025-07-02:** Analysts are discussing Schrodinger Inc's (SDGR) recent performance and its outlook in the context of industry trends and global economic factors.
*   **2025-07-03:** Schrodinger Inc (SDGR)'s stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **2025-07-05:** Market experts highlight both risks and opportunities for Schrodinger Inc (SDGR), advising investors to monitor recent news and company announcements.

**Analysis:** Recent news suggests potential business developments, analyst discussions about performance, and notable stock volatility, indicating a period of significant change and uncertainty for the company.

**5. Recent Earnings Analysis**

| 날짜       | EPS    | 매출      |
|------------|--------|-----------|
| 2025-05-07 | -0.82  | 0.06 B$   |
| 2024-11-12 | -0.52  | 0.04 B$   |
| 2024-07-31 | -0.74  | 0.05 B$   |
| 2024-05-01 | -0.76  | 0.04 B$   |
| 2025-05-07 | -0.76  | 0.04 B$   |

**Analysis:** The company consistently reports negative EPS (Earnings Per Share), indicating unprofitability. Revenue is relatively low and fluctuates slightly quarter to quarter.

**6. Financial Information**

Revenue and Profitability:

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-03-31 | \$0.06B | 52.26%        |
| 2024-12-31 | \$0.09B | 72.61%        |
| 2024-09-30 | \$0.04B | 50.24%        |
| 2024-06-30 | \$0.05B | 66.20%        |
| 2024-03-31 | \$0.04B | 51.61%        |

Capital and Profitability:

| Quarter    | Equity  | ROE       |
|------------|---------|-----------|
| 2025-03-31 | \$0.37B | -16.01%   |
| 2024-12-31 | \$0.42B | -9.54%    |
| 2024-09-30 | \$0.45B | -8.49%    |
| 2024-06-30 | \$0.47B | -11.40%   |
| 2024-03-31 | \$0.51B | -10.65%   |

**Analysis:** While the profit margins are high, the company's ROE (Return on Equity) is negative, indicating inefficiency in generating profit from equity. Additionally, the equity is decreasing over the observed quarters.

**7. Overall Summary**

Schrodinger Inc. (SDGR) presents a concerning picture based on the provided data.

*   **Underperformance:** The stock has significantly underperformed the S&P 500 with a large divergence and negative alpha.
*   **Financials:** The company is consistently unprofitable (negative EPS) and has negative ROE, even though profit margins can be high. Equity is declining.
*   **Technicals:** Technical indicators suggest the stock might be oversold, but the overall trend is downward.
*   **Risk:** The exceptionally negative expected return signals a high degree of risk. The news indicates volatility and ongoing discussions about the company's performance.

**Conclusion:**  Based on this analysis, SDGR appears to be a high-risk investment. The consistent losses, underperformance, and negative outlook warrant extreme caution. Further in-depth research is strongly recommended before considering any investment.
